KIP Global Pharma Private Equity Fund
Venture Capital
Sector-specific private equity fund by Korea Investment Partners targeting pharmaceuticals, semiconductors, and software investments in South Korea.
Seoul, South Korea · 4+ investments · 510 portfolio companies
Growth
Late Stage
Biotech
Healthcare
Semiconductors
- Headquarters
- Seoul, South Korea
- Website
- partners.koreainvestment.com
- Portfolio Companies
- 510
- Total Investments
- 4
- Last Investment
- Jan 2016
- Geographic Focus
- Asia, South Korea
Investment Thesis
Sector-focused PE fund under Korea Investment Partners targeting Korean pharmaceutical and life sciences companies with diagnostics and medical businesses.
KIP Global Pharma Private Equity Fund is a Venture Capital firm based in Seoul, South Korea. It has made 4 investments in Biotech and Healthcare, including Elisigen, Philoptics and J&John.
Portfolio510
E
ElisigenP
PhilopticsJ
J&JohnS
SkyLabsSO
Studio Origin
O
OhmyhomeN
NeuroVentiS
SawnicsL
LinkGenesisPT
Pin TherapeuticsQL
Quota LabFC
Future ConnectT
TribeXT
TCUBEit
3
3HelixGC
GL ChemPI
Pharos iBioS
SMLABB
BESTRL
LabincubeKE
KY EntertainmentCM
Care MediL
LigaChemBioP
PromediusI
IMGTFG
Friends GamesM
MinTechA
ACTIVONDK
Dstrict KoreaP
PloonetV
VSIG
GuHaDaT
theonederD&
Drama & CompanyPT
Pinetree TherapeuticsBS
BlueStack SystemsMJ
Mighty Jaxx International Pte.L
LillemL
LessengersRC
REVU CorporationInvestment History
Sign up to view investment history
Create a free account — 25 credits a month to unlock deal history, amounts, and round details.


